DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Pascual J, Munoz R, Leira R.
An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
Cephalalgia 2001; 21: 680-684
We do not assume any responsibility for the contents of the web pages of other providers.